These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 17971644
1. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention. Fuentes B, Ortega-Casarrubios MA, Martínez P, Díez-Tejedor E. Cerebrovasc Dis; 2007; 24 Suppl 1():96-106. PubMed ID: 17971644 [Abstract] [Full Text] [Related]
2. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Fuentes B, Martínez-Sánchez P, Díez-Tejedor E. Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842 [Abstract] [Full Text] [Related]
3. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future. Piechowski-Jóźwiak B, Bogousslavsky J. Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057 [Abstract] [Full Text] [Related]
4. Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials. Segall L, Oprisiu R, Fournier A, Covic A. J Nephrol; 2008 Jun; 21(3):374-83. PubMed ID: 18587726 [Abstract] [Full Text] [Related]
6. Primary and secondary prevention of stroke by antihypertensive drug treatment. Wang JG, Li Y. Expert Rev Neurother; 2004 Nov; 4(6):1023-31. PubMed ID: 15853529 [Abstract] [Full Text] [Related]
9. Antihypertensive medications for risk reduction of first and recurrent ischemic stroke. Padma V, Fisher M, Moonis M. Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):867-76. PubMed ID: 15500432 [Abstract] [Full Text] [Related]
10. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study. Dowlatshahi D, Hill MD. Expert Rev Cardiovasc Ther; 2009 May; 7(5):459-64. PubMed ID: 19419253 [Abstract] [Full Text] [Related]
11. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F. Nefrologia; 2008 May; 28 Suppl 3():39-48. PubMed ID: 19018737 [Abstract] [Full Text] [Related]
12. [Treatment in the primary prevention of stroke--still not fully used option]. Widimský J. Cas Lek Cesk; 2004 May; 143(10):657-63. PubMed ID: 15584613 [Abstract] [Full Text] [Related]
14. [Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure]. Lenders JW, Thien T. Ned Tijdschr Geneeskd; 2002 Mar 02; 146(9):398-9. PubMed ID: 11901939 [Abstract] [Full Text] [Related]
15. Management of hypertension and cerebrovascular disease in the elderly. Pedelty L, Gorelick PB. Am J Med; 2008 Aug 02; 121(8 Suppl):S23-31. PubMed ID: 18638616 [Abstract] [Full Text] [Related]
16. Stroke prevention with lipid-lowering therapy. Piechowski-Jozwiak B, Bogousslavsky J. Expert Rev Neurother; 2004 Mar 02; 4(2):233-9. PubMed ID: 15853564 [Abstract] [Full Text] [Related]
17. Blood pressure-lowering treatment for primary and secondary prevention of different types of stroke. Arima H. Expert Rev Cardiovasc Ther; 2009 Jun 02; 7(6):627-36. PubMed ID: 19505278 [Abstract] [Full Text] [Related]
19. Do thiazide diuretics confer specific protection against strokes? Messerli FH, Grossman E, Lever AF. Arch Intern Med; 2003 Nov 24; 163(21):2557-60. PubMed ID: 14638555 [Abstract] [Full Text] [Related]